Ligand validation:5FHZ

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 5FHZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5FHZ_NAD_C_601	65%	45%	0.171	0.975	0.88	1.24	1	5	5	0	100%	1
5FHZ_NAD_F_601	57%	46%	0.175	0.95	0.89	1.18	2	6	4	0	100%	1
5FHZ_NAD_G_601	56%	43%	0.168	0.942	0.92	1.27	3	6	6	0	100%	1
5FHZ_NAD_B_601	56%	41%	0.189	0.962	0.84	1.44	2	8	3	0	100%	1
5FHZ_NAD_A_601	55%	33%	0.186	0.957	1.08	1.55	2	8	1	0	100%	1
5FHZ_NAD_D_601	55%	37%	0.192	0.961	0.97	1.5	2	11	4	0	100%	1
5FHZ_NAD_H_601	43%	42%	0.212	0.936	0.92	1.32	2	6	2	0	100%	1
5FHZ_NAD_E_601	34%	38%	0.231	0.916	0.94	1.49	3	7	5	0	100%	1
7QK8_NAD_B_1302	74%	66%	0.126	0.955	0.57	0.75	-	2	0	0	100%	0.853
6TGW_NAD_A_601	60%	1%	0.164	0.95	5.45	1.99	16	6	5	0	100%	1
6TRY_NAD_B_801	48%	1%	0.193	0.935	5.43	1.93	16	8	8	0	100%	1
6TE5_NAD_B_701	45%	46%	0.191	0.925	0.84	1.24	2	7	11	0	100%	1
7A6Q_NAD_A_601	39%	2%	0.206	0.913	5.57	1.71	17	6	13	0	100%	1
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.